Active Ingredient (In Each Tablet)
Diphenhydramine HCl 25 mg
The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Banophen (NDC 0904-5551). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Diphenhydramine HCl 25 mg
Antihistamine
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| adults and children 12 years and over | 1 to 2 tablets |
| children 6 to under 12 years | 1 tablet |
| children under 6 years | do not use |
corn starch, D&C red #27 aluminum lake, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, silicon dioxide, stearic acid, talc, titanium dioxide
MAJOR®
NDC 0904-5551-24
*Compare to the active ingredient in Benadryl® Allergy ULTRATAB® Tablets*
BANOPHEN™
Diphenhydramine HCl 25 mg
Antihistamine
MINITABS
Complete Allergy Medication
For the temporary relief of the symptoms of:
• Upper Respiratory Allergies • Hay Fever
24 MINITABS
*This product is not manufactured or distributed by Johnson & Johnson Corporation, owner of the registered trademark Benadryl® Allergy ULTRATAB® Tablets.
50844 REV1016L32908
Distributed by MAJOR® PHARMACEUTICALS
17177N Laurel Park Drive, Suite 233
Livonia, MI 48152 USA M-17
Re-order No. 250050
Rev. 01/17
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING
* Please review the disclaimer below.